LESAKA TECHNOLOGIES,
INC.
Unaudited
Condensed Consolidated
Statements
of Cash Flows
7
2026
2025
(In thousands)
Cash flows from operating activities
Net loss
(A)
$
(4,183)
$
(4,775)
Depreciation and amortization
9,973
12,894
Movement in allowance for doubtful
accounts receivable and finance
loans receivable
4,523
2,606
Earnings from equity
-accounted investments (Note 6)
(69)
-
Fair value adjustment related to financial liabilities
(265)
(1)
Interest payable
25
(107)
Facility fee amortized
162
78
Net loss on disposal of equity-accounted investments (Note
6)
-
584
Profit on disposal
of property, plant and equipment
(6)
(30)
Stock-based compensation charge (Note 13)
1,370
1,861
Changes in net working
capital
Increase in accounts receivable and other receivables
(7,787)
(1,230)
Increase in finance loans receivable
(15,574)
(6,903)
(Increase) decrease in inventory
(3,900)
5,148
Increase (decrease) in accounts payable and other payables
(A)
10,128
(233)
Increase in taxes payable
942
512
Decrease in deferred taxes
(2,140)
(1,481)
Net cash (used in) provided by operating
activities
(6,801)
8,923
Cash flows from investing activities
Capital expenditures
(8,243)
(3,980)
Proceeds from disposal
of property, plant and equipment
465
452
Acquisition of
intangible assets
(829)
(1,139)
Acquisition of
insurance entity investments
(65)
-
Acquisition of
equity-accounted investment
(750)
-
Repayment of loans by equity-accounted investments
200
-
Net change in settlement assets
(323)
4,206
Net cash used in investing activities
(9,545)
(461)
Cash flows from financing activities
Proceeds from bank overdraft (Note
9)
59,536
27,974
Repayment of bank overdraft (Note
9)
(41,780)
(40,661)
Long-term borrowings
utilized (Note 9)
4,082
2,763
Repayment of long
-term borrowings (Note
9)
(1,189)
(1,148)
Repurchase of shares of common stock (Note
13)
(186)
-
Non-refundable
deal origination fees (Note 9)
-
(33)
Net change in settlement obligations
120
(3,633)
Net cash provided by (used in) financing activities
20,583
(14,738)
Effect of exchange rate
changes on cash
132
1,921
Net increase (decrease)
in cash, cash equivalents and restricted cash
4,369
(4,355)
Cash, cash equivalents
and restricted cash – beginning of period
81,538
76,639
Cash, cash equivalents
and restricted cash – end of period (Note 15)
$
85,907
$
72,284
(A) Revised to correct the errors discussed in Note 1.
See Notes to Unaudited Condensed
Consolidated Financial Statements